Related Experiment Video
Updated: Oct 22, 2025

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Pediatric Acute Ischemic Stroke by Age-Group: A Systematic Review and Meta-Analysis of Published Studies and
Denise M Oleske1, Xianbin Cheng2, Anna Jeong3
1Global Epidemiology, AbbVie, North Chicago, Illinois, USA.
Insights
Pediatric acute ischemic stroke (AIS) is rare but serious. Incidence rates show a reverse J-shaped curve, highest in neonates and older children, with significant variation by country.
Area of Science:
- Pediatric Neurology
- Epidemiology
- Public Health
Background:
- Pediatric stroke, though rare, carries severe consequences.
- Etiologic factors for acute ischemic stroke (AIS) in children vary with age.
- Systematic examination of pediatric AIS incidence by age subgroup is needed.
Approach:
- Conducted a systematic literature review (1983-2020) and analyzed European/US hospitalization records (2015-2018).
- Collated data on AIS diagnosis codes and age-specific incidence rates for children aged 0-17/18 years.
- Performed meta-analysis to assess heterogeneity of AIS rates in neonates.
Key Points:
- Pooled AIS incidence rate was 4.6 per 100,000 children (full age range).
- Incidence varied significantly by country, from 7.0 (Germany) to 1.3 (Denmark) per 100,000.
- Highest rates observed in neonates (24.6/100,000), declining in early childhood, and rising in adolescence.
Conclusions:
- Pediatric AIS incidence follows a reverse J-shaped curve, peaking in neonates and adolescents.
- Consistent pattern observed primarily in European and North American countries.
- Further research is needed to explore geographic variations and identify age-specific risk factors.
Background:
Although stroke is rare among the pediatric population, it is nevertheless associated with serious or life-threatening consequences. The etiologic factors of acute ischemic stroke (AIS) are likely to vary over the course of childhood development. The incidence rates of AIS, not previously systematically examined by pediatric age subgroup, could guide studies of its etiology.
Objective:
The aim of this study is to evaluate the incidence rate of AIS by age-group in the pediatric population (aged 0-17/18 years) and identify any common trends or sources of variability across different countries.
Methods:
Rates of pediatric AIS were collated from a systematic literature review of published studies globally (1983-2020) and hospitalization records from Europe and the USA (2015-2018). Records that were included in the analysis reported the code or description used for AIS diagnosis and age-specific data for children aged 0-17/18 years. AIS incidence rates were summarized by age-group, data source, country, and geographic region. A meta-analysis was conducted to assess the heterogeneity of AIS rates in neonates.
Results:
The pooled AIS incidence rate was 5.6 per 100,000 children across all records. When only records reporting the AIS incidence rates for children across the full age range (0-17/18 years) were analyzed, the pooled AIS incidence rate was 4.6 per 100,000 children and ranged from 7.0 per 100,000 (Germany) to 1.3 per 100,000 (Denmark). The highest pooled rates were observed in the 0-28-day age-group (24.6 per 100,000 live births), declining to the lowest rates in the 5-9-year age-group, and rising again in the 10-17/18-year age-group. AIS rates were the most heterogeneous in the 0-28-day age-group and across European countries. Significantly higher AIS rates in neonates were observed from hospital databases (35.9 per 100,000) than in the literature (19.4 per 100,000). AIS rates may be underestimated as pediatric AIS events are rare and challenging to diagnose, and limited age-specific data are available.
Conclusions:
Incidence rates of pediatric AIS by age-groups followed a consistent overall pattern of a reverse J-shaped curve, with the highest rates in neonates, across predominantly European and North American countries. Further research is warranted to examine if this pattern is observed in other geographic regions and to identify AIS risk factors specific to different phases of childhood development.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children

